Tyler Cox
Physician Assistant · Philadelphia, PANPI 1518417955
Payments from drug & device makers
Across 202 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$1K
- Gilead$783
- Lilly USA, LLC$439
- Merck$374
- Novo Nordisk$162
- Janssen Products, LP$100
- plus $543 from 15 others
What the payments were for
- Food & beverage$3,46597%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 75 | $1,165 |
| Gilead | 48 | $783 |
| Lilly USA, LLC | 21 | $439 |
| Merck | 20 | $374 |
| Novo Nordisk | 8 | $162 |
| Janssen Products, LP | 1 | $100 |
| AbbVie | 4 | $89 |
| GSK | 5 | $80 |
| Bayer | 4 | $74 |
| Pfizer | 2 | $48 |
| AstraZeneca | 3 | $40 |
| Johnson & Johnson | 2 | $39 |
| Verona Pharma, Inc. | 1 | $31 |
| Cipher Pharmaceuticals US LLC | 1 | $25 |
| Amgen | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Phadia US Inc. | 1 | $14 |
| Hologic Inc | 1 | $13 |
| Mylan Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,564 in reported general payments places this provider in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 125 | $496,475 |
| CabenuvaCabotegravir/Rilpivirine | 24 | $143,237 |
| DovatoDolutegravir Sodium/Lamivudine | 44 | $131,989 |
| TrulicityDulaglutide | 102 | $104,507 |
| JardianceEmpagliflozin | 106 | $92,024 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 95 | $45,079 |
| OzempicSemaglutide | 30 | $31,239 |
| EliquisApixaban | 32 | $30,721 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 44 | $27,436 |
| JanuviaSitagliptin Phosphate | 33 | $23,259 |
| EntrestoSacubitril/Valsartan | 23 | $21,612 |
| XareltoRivaroxaban | 25 | $20,098 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 30 | $12,519 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 85 | $8,473 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 268 | $7,759 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy | $783 | $496,475125 claims |
| Viiv Healthcare CompanyCabenuva, Dovato | $1,165 | $275,22768 claims |
| Lilly USA, LLCTrulicity | $439 | $104,507102 claims |
| GSKAnoro Ellipta, Trelegy Ellipta, Breo Ellipta | $80 | $78,542154 claims |
| Novo NordiskOzempic | $162 | $31,23930 claims |
| PfizerEliquis | $48 | $30,72132 claims |
| MerckJanuvia | $374 | $23,25933 claims |
| Johnson & JohnsonXarelto | $39 | $20,09825 claims |
| AstraZenecaBevespi Aerosphere, Symbicort | $40 | $15,26643 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.
Other physician assistant in Philadelphia
- Melissa FerrariPhiladelphia$223K
- Alvin KingcadePhiladelphia$101K
- Trevor BonneyPhiladelphia$44K
- Ashwin GuptaPhiladelphia$33K
- Christopher EsworthyPhiladelphia$31K
- Carolyn ZawislakPhiladelphia$29K
- Kristen JonesPhiladelphia$22K
- Simone HoldenPhiladelphia$17K
- Erin CrownState College$1.5M
- Tricia BootsCranberry Twp$313K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.